Ads by Google

Mesothelioma Cancer

Mesothelioma Cancer Survivor Offers Hope After 6 Years

Let's start with Mesothelioma hope. A new drug mixture of tremelimumab and Imfinzi (durvalumab) show encouraging results in the first phase II mesothelioma clinical trial examining this combination. The study, which included 40 mesothelioma patients in Italy, was published in the June 2018 edition of The Lancet Respiratory Medicine.